Anavex Life Sciences Corp (AVXL)

[makemydaze]

Is this also an admission that 2-73 has broader potential?

"As far as today’s tie-up goes, Allergan will clearly have studied the muscarinic space before settling on Heptares, which Mr Weir said had the most advanced project. Anavex’s phase II asset ANAVEX 2-73 is a muscarinic agonist, but also agonises the sigma-1 receptor, which Mr Weir said meant that it lacked HTL18318’s selectivity."

http://epvantage.com/Universal/View.aspx?type=Story&id=632030&isEPVantage=yes